Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.
23 people · 0 jobs
10 people · 0 jobs
13 people · 0 jobs
11 people · 0 jobs
8 people · 0 jobs
6 people · 0 jobs
Editas Medicine
5 followers
Arcus Biosciences
3 followers
Gilead Sciences
163 followers
Regeneron
135 followers
Illumina
79 followers
Agilent Technologies
85 followers
Verily Life Sciences
46 followers
Alexion Pharmaceuticals
45 followers
GRAIL
29 followers
Cytiva
19 followers
CRISPR Therapeutics
13 followers
Explore companies